6th Symposium on Coronary Artery Anomalies

  05 Dec 2024 - 07 Dec 2024

   Houston, TX, United States

conference-img

6th Symposium on Coronary Artery Anomalies

05 Dec 2024

 - 

07 Dec 2024

Houston, TX, United States



Sudden cardiac death (SCD) in the young is a rare but devastating event that affects families and communities. Anomalous aortic origin of coronary artery (AAOCA) is the second leading cause of SCD in young athletes. The absolute risk is unknown, thus controversy exists regarding patient evaluation and management

This symposium is designed to provide a dedicated forum to discuss the diagnosis and management of patients with coronary artery anomalies (CAA). Topics will include anomalous aortic origin of a coronary artery (AAOCA) and myocardial bridges.

International Conference on Medical and Health Sciences

On: 25 May 2026

-

26 May 2026


International Conference on Sexual and Reproductive Health

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026


International Conference on Medical and Health Sciences

On: 25 May 2026

-

26 May 2026


International Conference on Sexual and Reproductive Health

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026



Whats more on Hidoc Dr.


Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

According to the CAPTIVATE Study, fixed-duration ibrutinib plus venetoclax may be beneficial for patients with high-risk chronic lymphocytic leukemia.

2.

Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness

3.

Vepdegestrant Earns FDA Nod for ESR1-Mutated Breast Cancer

4.

According to a study, taking part in a clinical trial for cancer may not actually increase survival.

5.

A new blood test greatly increases the ability to detect cancer.

Recommended News For You

Conferences That Might Interest You

Recommended Articles For You

Boost Your Knowledge With These Quizzes





© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot